Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Protalix BioTherapeutics Inc

+ Add to Watchlist


2.2300 USD 0.0100 0.45%

As of 20:04:03 ET on 04/24/2015.

Company Profile for Protalix BioTherapeutics Inc (PLX)

Protalix BioTherapeutics Inc. is a biotechnology company that has developed plant cell culture technology and a bioreactor system.

Contact Information

Protalix BioTherapeutics Inc

2 Snunit Street
Science Park PO Box 455
Carmiel, 20100
Phone: 972-4-988-9488
Fax: 972-4-988-9489

Key Executives for Protalix BioTherapeutics Inc (PLX)

Moshe ManorPresident/CEOTzvi PalashChief Operating Officer
Yoseph ShaaltielExec VP:Research & DevelopmentYossi MaimonVP/CFO/Treasurer/Secretary
Sandra L LauterbachVP:Sales & Commercial AffairsEinat Brill AlmonVP:Product Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil